'Magnificent Seven' profit lag: How the rest of the stock market may outpace tech giants this earnings season

Analysts expect Magnificent Seven earnings to grow 20.3% year over year in Q3, below the projected 27.7% growth for the rest of the S&P 500—a reversal from Q2, when the group’s earnings doubled. Market breadth remains weak: the equal-weight S&P 500 is about 6% below its record, and 75% of constituents ended September down. Strategists see the earnings season as a potential catalyst for broader participation and opportunities in lagging sectors, but broader earnings growth may not guarantee a wider rally; Russell Investments’ BeiChen Lin sees the S&P 500 ending the year 5% higher than its current level.

Analysis

The key signal is not the forecast growth gap itself, but whether forward estimates and price breadth confirm it. Slower Mag-7 growth is not necessarily earnings deterioration; high prior-year comparisons can make relative growth look weaker while mega-cap earnings still expand. Conversely, aggregate S&P growth can be lifted by a few sectors, so the headline does not establish that the median company is improving. Track estimate revisions, beat rates, and guidance breadth—not just reported EPS.

For the next 1–3 months, earnings from banks, credit-card issuers, healthcare and small caps could test whether September’s underperformance was a temporary valuation/positioning dislocation or a rational response to higher yields and oil. DAL and PEP are early read-throughs on travel demand, costs and consumer pricing, but neither alone can validate a broad rotation. Higher yields or renewed oil strength could pressure rate-sensitive small caps and consumer margins even with decent results. Over 6–18 months, sustained broadening would reduce index dependence on a handful of AI-linked stocks; it would not by itself disprove the AI investment cycle.

Contrarian risk: a rotation narrative may already be crowded after weak breadth, while the Mag-7 can retain index leadership if earnings revisions remain concentrated there. A broad earnings beat without improving equal-weight performance would be a warning that fundamentals are not translating into flows. Confirm with relative performance and revisions before treating the growth forecasts as a catalyst.

Key Decisions for Investors

• Prefer a conditional relative-value expression over an outright market call: scale into beta-adjusted long RSP / short SPY only if equal-weight relative strength stabilizes or improves through the reporting cycle and non-mega-cap forward revisions broaden. Risk: close or reduce if RSP resumes making relative lows, or if mega-cap revisions re-accelerate.
• Keep XLF and small-cap exposure on a watchlist rather than buying the earnings-growth forecast alone. Add only after bank guidance and credit-cost commentary support the thesis and Treasury yields/oil stop rising; worsening loan-loss trends or renewed rate/energy shocks falsify it.
• Use DAL and PEP results as narrow, not market-wide, checks on travel demand, consumer pricing and input-cost pressure. Verify guidance and margins against expectations; do not infer a broad consumer turn from either report in isolation.
• Near-term risk control: avoid assuming weaker relative Mag-7 growth means an imminent reversal in NVDA or the AI complex. Reassess if index leadership remains narrow while non-mega-cap estimate revisions fail to improve; that would favor cap-weighted exposure over a rotation trade.